Kuros Biosciences(CH:KURN)
CHF 20.10+0.52 (+2.66%)
CH:KURN
Kuros Biosciences Revenue
CHF 20.10
At close:+0.52 (+2.66%)
Want to see CH:KURN full AI Analyst Report?
Kuros Biosciences (KURN) Revenue
10 Followers
Kuros Biosciences Revenue
Kuros Biosciences had a revenue of 72.67M in the quarter ending Jun 30, 2026, with 10.04%. This bring the company's revenue in the last twelve months to 138.71M, Increased 7.10%. In the fiscal year ending Dec 31, 2025, Kuros Biosciences had annual revenue of 121.30M with 60.54% growth.
- Revenue (ttm)
- 138.71M
- Revenue Growth
- 40.91%
- P/S Ratio
- 6.43
- Revenue/Employee
- CHF 569,480
- Employees
- 213
- Market Cap
- CHF 779.80M
Revenue Chart
Kuros Biosciences Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 121.30M | 45.74M | 60.54% |
| Dec 31, 2024 | 75.56M | 41.99M | 125.11% |
| Dec 31, 2023 | 33.56M | 15.58M | 86.61% |
| Dec 31, 2022 | 17.99M | 4.17M | 30.19% |
| Dec 31, 2021 | 13.81M | 9.78M | 242.04% |
| Dec 31, 2020 | 4.04M | 1.48M | 57.71% |
| Dec 31, 2019 | 2.56M | 1.85M | 258.18% |
| Dec 31, 2018 | 715.00K | 181.00K | 33.90% |
| Dec 31, 2017 | 534.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.